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We investigated interactions of bispyridinium para-aldoximes N,N’-(propano)bis(4-hydroxyiminomethyl)
pyridinium bromide (TMB-4), N,N’-(ethano)bis(4-hydroxyiminomethyl)pyridinium methanosulphonate 
(DMB-4), and N,N’-(methano)bis(4-hydroxyiminomethyl)pyridinium chloride (MMB-4) with human 
erythrocyte acetylcholinesterase phosphorylated by tabun. We analysed aldoxime conformations to 
determine the flexibility of aldoxime as an important feature for binding to the acetylcholinesterase active 
site. Tabun-inhibited human erythrocyte acetylcholinesterase was completely reactivated only by the most 
flexible bispyridinium aldoxime - TMB-4 with a propylene chain between two rings. Shorter linkers than 
propylene (methylene or ethylene) as in MMB-4 and DMB-4 did not allow appropriate orientation in the active 
site, and MMB-4 and DMB-4 were not efficient reactivators of tabun-phosphorylated acetylcholinesterase. 
Since aldoximes are also reversible inhibitors of native acetylcholinesterase, we determined dissociation 
constants and their protective index against acetylcholinesterase inactivation by tabun.
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Progressive inhibition of acetylcholinesterase 
(AChE; EC 3.1.1.7) by an organophosphorus 
compound such as the nerve agent tabun is due to the 
phosphorylation of the active centre serine characterised 
by the formation of a conjugate and inactivation of 
this enzyme essential for neurotransmission. A 
combination of an antimuscarinic agent e.g. atropine 
and an AChE reactivator such as aldoxime is used 
for the treatment of organophosphorus compound 
poisoning. However, despite intense research on 
reactivation, no aldoxime has been efficient against 
a variety of agents, because efficiency varies with the 
structures of both the organophosphorus compound 
bound and of the reactivator (1, 2). Tabun is one of the 
most potent organophosphorus poisons due to the 
oxime-resistant reactivation of tabun-phosphorylated 
acetylcholinesterase. TMB-4 is one of the classical 
aldoximes and a potent reactivator of AChE inhibited 
by tabun (cf. 2). Our recent reactivation studies with 
pyridinium aldoximes, similar to TMB-4, with the 
para-positioned oxime group gave promising results 
in reactivating tabun-phosphorylated AChE and in 
the therapy of tabun-poisoned mice (3, 4). In this 
paper we continued the in vitro investigation using 
three known bispyridinium para-aldoximes TMB-4, 
DMB-4 and MMB-4 with the aim to relate molecular 
properties of the aldoxime to its reactivation potency. 
Therefore, we performed the conformational analysis 
of the aldoximes and determined reactivation rate 
constants of human erythrocyte AChE inhibited by 
tabun. Moreover, we determined aldoxime protective 
potency against AChE inhibition by tabun, because 
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in addition to acting as reactivators, aldoximes are 
also reversible inhibitors of AChE, and therefore they 
can protect the catalytic site against phosphorylation 
due to a direct competition between them and the 




hydroxyiminomethyl)pyridinium bromide (TMB-4) 
was obtained from Bosnalijek, Sarajevo, Bosnia and 
Herzegovina; N,N’-(ethano)bis(4-hydroxyiminome-
thyl)pyridinium methanosulphonate (DMB-4) and 
N,N’-(methano)bis(4-hydroxyiminomethyl)pyridinium 
chloride (MMB-4) were obtained from the US Army 
Medical Research Institute of Chemical Defense, 
Aberdeen Proving Ground, MD, USA. Aldoximes were 
kept at room temperature and dissolved in water 
immediately before use. Tabun was purchased from 
NC Laboratory, Spiez, Switzerland. Acetylthiocholine 
iodide (ATCh) and 5,5’-dithiobis(2-nitrobenzoic acid) 
(DTNB) were purchased from Sigma Chemical Co., 
St. Louis, MO, USA.
Conformational analysis of aldoximes
Conformational analysis (Table 1) was performed 
using MM2 and semi-empirical calculations with 
MOPAC 2000 software (PM-3 method with COSMO 
solvation model) created by J.J.P. Stewart (Fujitsu 
Ltd., Tokyo, Japan, 1999) according to published 
procedures (7, 8).
AChE activity measurement
Native non-haemolysed human erythrocytes 
were the source of AChE; the final dilution during 
enzyme assay was 400-fold. All experiments were 
done in 0.1 mol L-1 sodium phosphate buffer, pH 
7.4, at 25 °C. The enzyme activity was measured 
spectrophotometrically according to the Ellman 
procedure (9) with the thiol reagent DTNB (0.3 
mmol L-1 final concentration) and the substrate ATCh. 
The increase in absorbance was read at 436 nm for 
1 min. All spectrophotometric measurements were 
performed on a CARY 300 spectrophotometer (Varian 
Inc., Australia).
Reactivation of tabun-inhibited AChE
Undiluted erythrocytes were incubated with 
5 µmol L-1 tabun up to 60 min achieving 90 % to100 % 
Table 1  Energy barriers (E, kcal mol-1) for rotation around single bonds in tested aldoximes. Energies were calculated using the MM2 method. 
Asterisk denotes averaged value due to symmetry in the molecule.
Rotation bond
TMB-4 DMB-4 MMB-4
E / kcal mol-1
N(3)-C(13) 0.7* 0.8* 3.3*
C(6)-C(19) 6.2* 6.2* 6.1*
C(13)-C(14) 27.3* 24.6 /
Table 2  Reactivation of tabun-inhibited human erythrocyte acetylcholinesterase by tested aldoximes. Constantsa (± standard errors) are calculated 
by Eqns. 1-3 from kobs constants obtained in at least three experiments. The maximal percent of reactivation (Reactmax) measured within 
the specified time of the experiment is also given.
Aldoxime (mmol L-1) k+2 / min
-1 KOX / mmol L
-1 kr / L mol
-1min-1 Reactmax / % Time
TMB-4 (0.05-10.0) 0.15±0.016 0.49±0.17 306±131 100 20 min
DMB-4 (0.1-3.0) 0.002±0.0001 0.048±0.015 41.7±13.2 70 16 h
MMB-4 (0.1-3.0) 0.004±0.0004 0.28±0.10 14.3±5.30 80 10 h
a k+2 – the maximum first order reactivation rate constant; kr – the overall second order reactivation rate constant; KOX – the dissociation constant 
of the phosphorylated enzyme and oxime
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inhibition. Incubation mixture was diluted 10 times 
with 0.1 mol L-1 phosphate buffer, pH 7.4, containing 
the aldoxime to start the reactivation. Final aldoxime 
concentrations used for the reactivation of tabun-
inhibited AChE are given in Table 2. After a given 
time of reactivation aliquots were diluted 40 times, 
DTNB and ATCh (1.0 mmol L-1 final concentration) 
were added, and the enzyme activity was measured. 
An equivalent sample of uninhibited enzyme was 
diluted to the same extent as the inhibited AChE, and 
control activity was measured in the presence of the 
aldoxime at concentrations used for reactivation. Both 
the activities of control and reactivation mixture were 
corrected for the oxime-induced hydrolysis of ATCh. 
No spontaneous reactivation of the phosphorylated 
enzyme took place.
Oxime-assisted reactivation of phosphorylated 
AChE proceeds according to Scheme 1:
 (Scheme 1)
where EP is the phosphorylated enzyme, [EP][OX] is 
the reversible Michaelis type complex between EP and 
the aldoxime (OX), E is the active enzyme, P-OX is the 
phosphorylated aldoxime, k+2 is the maximum first 
order rate constant, and kr is the overall second order 
rate constant of reactivation. Scheme 1 is defined by 
the following equation: 
 (Eqn. 1)
where [EP]0 and [EP]t are the concentrations of the 
phosphorylated enzyme at time zero and at time t,
respectively. KOX is equal to the ratio (k-1 + k+2)/k+1,
and it approximates the dissociation constant of the 
[EP][OX] complex. kobs is the observed first-order 
rate constant of reactivation at a given aldoxime 
concentration. The overall second-order rate constant 
of reactivation (kr) is the ratio
(Eqn. 2) 
Experimental data were presented as the percentage 
of reactivation 
(Eqn. 3)
where v(EP + OX)t is the activity of reactivated enzyme 
at time t, and v(E + OX) stands for the activity of the 
enzyme incubated with aldoxime. Since (100-% 
Reactivation) is equal to 100 [EP]t/[EP]0, one can relate 
the experimental data to Eqn. 1. At each aldoxime 
concentration, kobs was calculated from the slope 
of the initial portion of log (100-% Reactivation) vs.
time of reactivation. Reactivation with each aldoxime 
followed Eqn. 1. Therefore, k+2 and KOX were obtained 
by the non-linear fit of the relationship between kobs vs.
[OX], while kr was calculated using Eqn. 2.
Reversible inhibition of AChE
Reversible inhibition of AChE by aldoximes was 
measured in a medium which contained erythrocytes 
suspended in buffer, DTNB, aldoxime, and ATCh. 
Aldoxime and substrate concentrations are given in 
Table 3.
The inhibition constants were evaluated from the 
effect of substrate concentration (s) on the degree of 
inhibition according to the equation:
Table 3  Reversible inhibition of human erythrocyte acetylcholinesterase by the aldoximes, protection with aldoximes (0.2 mmol L-1) against 
phosphorylation of human erythrocyte acetylcholinesterase by tabun and non-enzymatic reaction of the acetylthiocholine with tested














TMB-4 (0.1-0.7) 0.05-0.7 0.18±0.01 0.96±0.16 0.13 2.6±0.0 2.1 31±0
DMB-4 (0.05-0.5) 0.1-1.0 0.10±0.02 0.74±0.19 0.12 2.7±0.4 3.0 29±1
MMB-4 (0.25-0.7) 0.1-1.0 0.49±0.07 0.48±0.09 0.40 1.5±0.1 1.4 32±1
Ki and K(S) –  the dissociation constant of the enzyme and oxime complex and of the enzyme and substrate complex, respectively; Ki theor – theoretically 
determined Ki by Eqn. 7; PI and PItheor – experimentally and theoretically determined protective index; kNE  –  the second-order rate constant of the 
non-enzymatic reaction
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Kapp is the apparent enzyme-aldoxime dissociation 
constant at a given substrate concentration (s), 
calculated from enzyme activities v0 and vi,measured
in the absence and in the presence of the aldoxime 
(i), respectively. Ki is the enzyme-aldoxime dissociation 
constant of a complex formed in the catalytic site, 
and K(S) is the enzyme-substrate dissociation constant 
which should correspond to the Michaelis constant 
(KM), if aldoxime binds only to the catalytic site.
Protection of AChE against phosphorylation
Protection of AChE against phosphorylation was 
measured in a medium which contained erythrocytes 
suspended in 0.1 mol L-1 phosphate buffer, DTNB, 
aldoxime (0.2 mmol L-1), and tabun (100 nmol L-1).
After a given time of inhibition (up to 5 min), ATCh 
(1.0 mmol L-1 final concentration) was added and the 
increase in absorbance was read for 1 min. Control 
samples contained no aldoxime.
The second-order rate constant of inhibition by 
tabun (ki) was calculated from the equation:
 (Eqn. 5)
where vOP and v0 are enzyme activities with and without 
the organophosphorus compound, respectively; OP is 
the concentration of tabun, and t is time of inhibition. 
Protection was expressed in terms of protective index 
(PI) which corresponds to the ratio:
 (Eqn. 6)
The second-order rate constant of inhibition in the 
presence of the aldoxime (k’i) was calculated using 
Eqn. 5 where v0 and vOP denote enzyme activities in the 
absence of both the aldoxime and organophosphorus 
compound, and in their presence, respectively.
Protective indexes for all tested aldoximes were 
also determined theoretically from:
PItheor= 1 + i/Ki (Eqn. 7)
where i stands for aldoxime concentration, and Ki
is the experimentally determined enzyme-aldoxime 
dissociation constant.
Oxime-catalysed hydrolysis of acetylthiocholine
The reaction of ATCh with aldoxime was measured 
for 1 min in a medium which contained ATCh, 
aldoxime, DTNB and 0.1 mol L-1 phosphate buffer, 
pH 7.4 at 25 °C. Aldoxime and ATCh concentrations 
are given in Table 3. Two to four measurements 
were done with each ATCh/aldoxime concentration 
pair. The second-order rate constant of the non-
enzymatic reaction (kNE) was calculated according to 
the following equation:
c / t = kNE × s × i (Eqn. 8)
where c is the released thiocholine concentration, 
t is the time of reaction, and s and i are the initial 
ATCh and aldoxime concentrations. The thiocholine 
concentration was calculated from the absorbance 
monitored at 436 nm (eM=11000 L cm
-1mol-1; 10). 
RESULTS AND DISCUSSION
Flexibility of aldoxime molecule is important 
for binding to AChE, i.e. for appropriate oxime 
group orientation towards phosphorylated catalytic 
serine. Therefore, we performed the conformational 
analysis of the aldoximes to relate their molecular 
properties to the studied AChE interactions. Table 1 
shows the energy barriers for rotation around single 
bonds in tested oximes, while the superposition 
of minimized aldoxime structures is presented in 
Figure 1. Aldoximes TMB-4 and DMB-4 were more 
flexible than MMB-4 due to the lower rotation barrier 
of the N(3)-C(13) bond. A higher rotation barrier in 
MMB-4 was probably caused by the steric hindrance 
of two pyridinium rings connected by a short linker. 
Pyridinium rings of MMB-4 are stabilised at an angle 
of about 90°, and for their rotation additional energy 
is required. Actually, we have recently shown that 
Figure 1 Superposition of minimised structures of para-aldoximes. 
Hydrogen atoms are not shown for better visibility.
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the rotation barrier of N(3)-C(13) bond distinguishes
para- from ortho-pyridinium aldoximes: 0.7 vs. 15 
kcal mol-1 (11). However, the rotation of the para-
positioned oxime groups around the bond C(6)-C(19) 
was similar in all three aldoximes. Bonds in the linker 
connecting atoms numbered 13 and 14, and atoms 
14 and 15 with the highest rotation energy barriers, 
determined the overall aldoxime rigidness. Very likely 
because of the linker rigidness, TMB-4 and DMB-4 
sterically better fitted the AChE active site gorge than 
MMB-4, as was shown in a previous docking study of 
aldoximes similar to MMB-4 (12).
Table 2 shows the kinetic parameters for the 
reactivation of tabun-inhibited human AChE by the 
aldoximes, and one representative experiment is 
shown in Figure 2. Only TMB-4 completely restored 
the enzyme activity. The overall reactivation rate 
of TMB-4 was the highest, primarily due to its 
fastest first-order reactivation rate. A relatively high 
percentage of maximum reactivation by DMB-4 
and MMB-4 was slowly obtained after more than 
10 hours. However, the reactivation by DMB-4 and 
MMB-4 was not complete, and the kinetics at longer 
time intervals deviated from the first-order process 
described in Eqn. 1. This deviation could be due 
to a fraction of the aged phosphorylated enzyme 
(due to the post-inhibitory dealkylation known as 
aging) and/or re-inhibition of the active enzyme by 
the phosphorylated oxime (13). It is known that the 
aging of tabun-inhibited human AChE is relatively slow 
(t0.5=13 h; 14). Although no data on the stability or 
inhibitory potency of tabun phosphorylated DMB-4 
or MMB-4 are available in literature, the conjugate 
of tabun and monopyridinium para-aldoxime 4-PAM 
was a poor inhibitor of AChE, which was attributed 
to a combination of steric factors and a reduction in 
the electro-positivity of the phosphorus atom (15). 
Since three aldoximes differ only in the length of 
the chain between pyridinium rings, we attributed 
the low efficiency of MMB-4 in reactivation to its 
molecular properties discussed above. We showed 
earlier that the flexible bispyridinium para-aldoxime 
Figure 2 Reactivation of tabun-inhibited human erythrocyte AChE by 
MMB-4. (A) A single data point indicates calculated percent of 
reactivation using Eqn. 3. (B) Slopes of the reactivation curve 
yield kobs constants. (C) kobs is plotted as a function of MMB-4
and the curve is fitted using Eqn. 1.
Figure 3  Reversible inhibition of human erythrocyte AChE by the 
aldoximes. Points indicate the calculated average Kapp from 
measured activities with acetylthiocholine in the presence 
of aldoximes using Eqn. 4. Lines represent linear regression 
analysis and y-intercepts represent Ki constants.
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with a butylene chain was a very potent reactivator 
of tabun-inhibited AChE (3, 11). However, potent 
reactivators were also butylene-linked bisoximes that 
instead of pyridinium had imidazolium rings (16). 
Indeed, bispyridinium para-aldoxime with shorter 
linker than propylene and longer than butylene or 
monopyridinium para-aldoximes were not effective 
tabun-phosphorylated reactivators (12, 17, 18). A 
reactivation study of diisopropylphosphoryl-AChE 
showed that the most promising bispyridinium para-
aldoxime was a propylene-linked bisaldoxime, while 
the most promising bispyridinium ortho-aldoxime was 
a heptylene-linked bisaldoxime (19). Crystal structures 
of complexes explained different requirements of the 
chain length for reactivation. This means that the most 
potent reactivators should span the active site of the 
phosphorylated AChE and pyridinium rings should be 
stabilised by aromatic residues in the peripheral site 
and choline binding site of AChE (20).
Since aldoximes are also reversible inhibitors of 
AChE, we determined the dissociation constants 
of aldoxime-human erythrocyte AChE complex 
(Table 3). Over the studied concentration range of 
acetylthiocholine, aldoxime binding to the catalytic site 
was competitive as shown in Figure 3. The catalytic 
site of AChE showed the highest affinity (lowest Ki)
for DMB-4, about five times higher than that for 
MMB-4. The determined Ki constants for DMB-4 and 
TMB-4 were similar to constants published for other
bispyridinium compounds (3), while for MMB-4 Ki was 
similar to Ki of monopyridinium aldoxime, 4-PAM 
(19), showing that the second ring in MMB-4 does 
not improve stabilisation of aldoxime binding. The 
K(S) values, derived from the kinetics of inhibition with 
aldoximes were higher, but close to the previously 
determined KM (21). This supports our belief that the 
determined Ki constants correspond to binding to the 
catalytic site of AChE. Higher substrate concentrations 
could not be used to determine possible aldoxime 
binding to the peripheral site of AChE because all 
three aldoximes reacted with acetylthiocholine, 
and this reaction interfered with the enzyme assay. 
Namely, the oxime group reacts with AChE substrate 
acetylthiocholine on a 1:1 molar basis, and thiocholine 
is one of the reaction products (11, 22). The rate 
constants for aldoxime-catalysed hydrolysis of 
acetylthiocholine are given in Table 3. Constants 
were similar to the rate constant obtained for LüH-6 
(obidoxime), a bis-pyridinium aldoxime (23).
The binding affinity of the aldoximes to the free 
enzyme did not correlate with aldoxime efficacy in 
enzyme reactivation (cf. Table 2). The phosphorylated 
AChE had a higher affinity for DMB-4 and MMB-4 
than free enzyme, i.e. KOX constants were about two 
times lower than the respective Ki. It seems that 
reactivation primarily depends on the displacement 
rate of the phosphorus moiety, because aldoxime 
with a high binding affinity could be stabilised far from 
the phosphorus atom. Relevant enzyme-aldoxime 
dissociation constant should perhaps be determined 
before starting reactivation experiments, because it 
might indicate the binding affinity of phosphorylated 
enzyme, which is expected to be lower (24).
As reversible inhibitors, aldoximes can protect the 
catalytic serine against phosphorylation, which means 
that even though oxime-mediated reactivation is poor, 
aldoximes could be used as prophylactic agents (4). 
Therefore, we measured progressive tabun inhibition 
of AChE in the absence and in the presence of 
aldoximes, and calculated protective indexes (PI; Table 
3). All tested aldoximes (0.2 mmol L-1) protected the 
enzyme from phosphorylation by tabun (Figure 4). As 
one could expect, MMB-4 showed a limited protection 
ability because MMB-4 concentration of 0.2 mmol L-1
is less than a half its Ki. Protective indexes for all 
tested aldoximes were also evaluated theoretically 
because the relationship between experimentally and 
theoretically obtained protective indexes could be 
used to determine the aldoxime binding site in AChE 
(25) and/or Ki constants. Experimentally obtained PI 
corresponded to the theoretically obtained PItheor, and 
so did Ki and Ki theor (cf. Table 3). Therefore, aldoximes 
protected the enzyme primarily by binding to the 
catalytic site.
Figure 4 Progressive inhibition of AChE by tabun in the absence and in 
the presence of aldoximes (0.2 mmol L-1) wherefrom protective 
indexes were determined. Slopes represent the first-order 
inhibition rate constants.
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In conclusion, the relationship between aldoxime 
potency to reactivate tabun-inhibited AChE and the 
length of its linker between two pyridinium rings, 
shown in this paper, confirmed previous related studies 
(17, 19). The potency of bispyridinium para-aldoxime 
to reactivate tabun-phosphorylated AChE decreases 
with its linker length, and the optimum length is 
three or four CH2 groups. We analysed aldoxime 
conformations to determine their flexibility as an 
important feature for binding to acetylcholinesterase 
active site. MMB-4 was the least flexible aldoxime, and 
showed limited reactivation potency. The most flexible 
and potent reactivator of tabun-phosphorylated AChE 
was TMB-4, which had the ability for nucleophilic 
attack, probably due to the stabilisation of the oxime 
group close to the phosphorus of the phosphorylated 
catalytic centre of AChE.
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Sa`etak
ODNOS STRUKTURE I AKTIVNOSTI U REAKTIVACIJI TABUNOM FOSFORILIRANE LJUDSKE 
ACETILKOLINESTERAZE BISPIRIDINIJEVIM para-ALDOKSIMIMA
Prou~avali smo interakcije bispiridinijevih para-oksima N,N’-(propano)bis(4-hidroksiiminometil)piridinijeva
bromida (TMB-4), N,N’-(etanano)bis(4-hidroksiiminometil)piridinijeva metanosulfonata (DMB-4) i N,N’-
(metano)bis(4-hidroksiiminometil)piridinijeva klorida (MMB-4) s ljudskom eritrocitnom acetilkolinesterazom 
fosforiliranom tabunom. Da bismo odredili fleksibilnosti aldoksima, {to je va`na osobina kod njihova 
vezanja u aktivno mjesto acetilkolinesteraze, analizirali smo i konformacijske odlike aldoksima. Ljudska 
acetilkolinesteraza inhibirana tabunom bila je potpuno reaktivirana samo najfleksibilnijim bispiridinijevim 
aldoksimom – TMB-4. Aldoksimi MMB-4 i DMB-4 nisu bili efikasni reaktivatori acetilkolinesteraze 
fosforilirane tabunom jer je kod tih spojeva lanac koji povezuje dva prstena kra}i od propilena (metilen 
u MMB-4 i etilen u DMB-4), {to ne dopu{ta povoljnu orijentaciju tih aldoksima unutar aktivnog mjesta 
enzima. S obzirom na to da su aldoksimi i reverzibilni inhibitori nativne acetilkolinesteraze, odredili smo 
njihove disocijacijske konstante, kao i za{titu acetilkolinesteraze od inhibiranja tabunom reverzibilnim 
vezanjem aldoksima.
KLJU^NE RIJE^I: antidoti, organofosforni spojevi, `iv~ani bojni otrovi
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